Correlates of high-dose antipsychotic prescription amongst outpatients with Schizophrenia in a Nigerian Hospital
- PMID: 35547105
- PMCID: PMC9082254
- DOI: 10.4102/sajpsychiatry.v28i0.1791
Correlates of high-dose antipsychotic prescription amongst outpatients with Schizophrenia in a Nigerian Hospital
Abstract
Background: Treatment guidelines recommend the use of antipsychotic monotherapy at effective doses for the treatment of schizophrenia, although about a third of the sufferers still receive high-dose antipsychotic treatment. Current evidence suggests that high-dose antipsychotic prescription (HDAP) not only fails to improve outcomes but also increases side effects.
Aim: Our study aimed to determine the prevalence of HDAP and its association with illness severity, medication adherence behaviour and side effects amongst outpatients with schizophrenia.
Setting: The Federal Neuro-Psychiatric Hospital, Benin-City, Nigeria.
Methods: A cross-sectional study of 320 attendees with schizophrenia at the outpatient department was undertaken. We administered a sociodemographic and antipsychotic medication questionnaire, Mini-International Neuropsychiatric Interview, Positive and Negative Syndrome Scale, Liverpool University Neuroleptic Side Effects Rating Scales and Medication Adherence Rating Scales. High-dose antipsychotic prescription was determined by the ratio of prescribed daily dose to defined daily dose greater than 1.5.
Results: The prevalence of HDAP was 38.4%. Greater severity of illness, experiencing more side effects and poor medication adherence were significantly associated with HDAP.The major predictors of HDAP were antipsychotic polypharmacy and concurrent anticholinergic use.
Conclusion: We conclude that although the use of HDAP amongst patients with schizophrenia remains common, its persistent use should be discouraged.
Keywords: Nigeria; antipsychotics; high dose; prescription; schizophrenia.
© 2022. The Authors.
Conflict of interest statement
The authors have declared that no competing interest exists.
Similar articles
-
Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital.Niger Postgrad Med J. 2020 Jan-Mar;27(1):30-36. doi: 10.4103/npmj.npmj_93_19. Niger Postgrad Med J. 2020. PMID: 32003359
-
Antipsychotic medication non-adherence and its determinants among out-patients with schizophrenia.Malawi Med J. 2025 Jan 13;36(4):288-297. doi: 10.4314/mmj.v36i4.8. eCollection 2025 Jan. Malawi Med J. 2025. PMID: 39877526 Free PMC article.
-
Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria.Ther Adv Psychopharmacol. 2017 Jan;7(1):3-10. doi: 10.1177/2045125316672134. Epub 2016 Oct 13. Ther Adv Psychopharmacol. 2017. PMID: 28101318 Free PMC article.
-
Antipsychotic polypharmacy in schizophrenia: benefits and risks.CNS Drugs. 2011 May;25(5):383-99. doi: 10.2165/11587810-000000000-00000. CNS Drugs. 2011. PMID: 21476610 Review.
-
Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.Int J Neuropsychopharmacol. 2021 Dec 8;24(12):956-964. doi: 10.1093/ijnp/pyab046. Int J Neuropsychopharmacol. 2021. PMID: 34245271 Free PMC article.
Cited by
-
Global Neuropsychopharmacological Prescription Trends in Adults with Schizophrenia, Clinical Correlates and Implications for Practice: A Scoping Review.Brain Sci. 2023 Dec 20;14(1):6. doi: 10.3390/brainsci14010006. Brain Sci. 2023. PMID: 38275511 Free PMC article.
-
Evaluation of Prescription Patterns of Antipsychotics in Schizophrenia Patients-A Single-Center Prospective Study.J Clin Med. 2025 Apr 24;14(9):2941. doi: 10.3390/jcm14092941. J Clin Med. 2025. PMID: 40363973 Free PMC article.
References
-
- Sadock BJ, Sadock VA. Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007.
-
- American Psychiatric Association . Schizophrenia and other psychotic disorders. In: American Psychiatric Association diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association, 2013; p. 89–122.
LinkOut - more resources
Full Text Sources